Identification and Functional Mechanism Verification of Novel MicroRNAs Associated with the Fibrosis Progression in Chronic Kidney Disease

Kaiying He,Xiaochun Zhou,Jing Zhao,Hongxuan Du,Juan Guo,Rongrong Deng,Jianqin Wang

DOI: https://doi.org/10.1007/s10528-024-10688-7

2024-02-07

Biochemical Genetics

Abstract:Chronic kidney disease (CKD) is a serious threat to human health worldwide, and its incidence is increasing annually. A growing amount of information is emerging about the role of micoRNAs (miRNAs) in the regulation of renal fibrosis, which has aroused interest in the development of drugs that block pathogenic miRNAs or restore protective miRNAs levels. To clarify the role of miRNAs in CKD, we selected patients with significant renal fibrotic disease (diabetic nephropathy (DN) and focal segmental glomerulosclerosis (FSGS)) as the disease group, and patients with little or no renal fibrotic disease (minimal change disease (MCD) and renal carcinoma adjacent to normal kidney) as controls. Significantly differentially expressed miRNAs were obtained by human kidney tissue sequencing, subsequently verified in mice models of DN and FSGS, and subsequently inhibited or overexpressed in human renal tubular epithelial cells (HK-2) stimulated by high glucose (HG) and TGF-β1 in vitro. Therefore, the mechanism of its action in renal fibrosis was further elaborated. Finally, the downstream target genes of the corresponding miRNAs were verified by bioinformatics analysis, qRT-PCR, western blot and double luciferase report analysis. Two novel miRNAs, hsa-miR-1470-3p (miR-1470) and hsa-miR-4483-3p (miR-4483), were detected by renal tissue sequencing in the disease group with significant renal fibrosis (DN and FSGS) and the control group with little or no renal fibrosis (MCD and normal renal tissue adjacent to renal carcinoma). Subsequent human renal tissue qRT-PCR verified that the expression of miR-1470 was significantly increased, while the expression of miR-4483 was markedly decreased in the disease group ( p < 0.05). Moreover, in vivo DN and FSGS mice models, the expression levels of miR-1470 and miR-4483 were consistent with the results of human kidney tissue. In vitro, miR-4483 was suppressed, whereas miR-1470 was induced by treatment with TGF-β1 or HG. Inhibition of miR-1470 or overexpression of miR-4483 promoted HG or TGF-β1-induced fibrosis in HK-2 cells. Further study revealed that MMP-13 and TIMP1 were the target genes ofmiR-1470 and miR-4483, respectively. Our study identifies newly dysregulated miRNA profiles related to fibrosis kidneys. miR-1470 and miR-4483 are demonstrated to participate in kidney fibrosis by regulation of MMP-13, TIMP1 respectively. Our results may represent a promising research direction for renal disorders and help identify new biomarkers and therapeutic targets for CKD.

genetics & heredity,biochemistry & molecular biology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is the identification of novel microRNAs (miRNAs) related to fibrosis progression in chronic kidney disease (CKD) and the verification of their functional mechanisms. Specifically, the research aims to:

1. **Identify novel miRNAs**: By analyzing kidney tissue samples from patients with significant renal fibrotic diseases such as diabetic nephropathy (DN) and focal segmental glomerulosclerosis (FSGS), screen out miRNAs that are differentially expressed in these patients.

2. **Verify the functional mechanisms of miRNAs**: Use mouse models and in vitro cell experiments (such as human renal tubular epithelial cells HK - 2) to verify the expression changes of these miRNAs under high - glucose (HG) and transforming growth factor β1 (TGF - β1) stimulation, and explore their roles in the process of renal fibrosis.

3. **Determine the downstream target genes of miRNAs**: Through bioinformatics analysis, qRT - PCR, Western blot and dual - luciferase reporter gene analysis and other methods, determine the specific target genes of these miRNAs and verify their regulatory relationships.

### Research Background

Chronic kidney disease (CKD) is a major threat to human health worldwide, and its incidence is increasing year by year. Renal fibrosis is the main cause of renal function loss and is considered the main pathological feature of end - stage renal disease (ESRD). Although it is known that miRNAs play an important role in the process of renal fibrosis, specific miRNAs and their regulatory mechanisms still need further study.

### Main Findings

1. **Identification of miR - 1470 and miR - 4483**: Through kidney tissue sequencing, two new miRNAs - hsa - miR - 1470 - 3p (miR - 1470) and hsa - miR - 4483 - 3p (miR - 4483) were detected in patients with significant renal fibrosis (DN and FSGS). Among them, miR - 1470 was significantly up - regulated in the disease group, while miR - 4483 was significantly down - regulated.

2. **Functional verification of miR - 1470 and miR - 4483**:
- In the mouse model, the expression levels of miR - 1470 and miR - 4483 were consistent with the results of human kidney tissue.
- In vitro experiments showed that miR - 4483 was inhibited, while miR - 1470 was induced to be expressed by high - glucose or TGF - β1.
- Inhibiting miR - 1470 or over - expressing miR - 4483 could promote the fibrosis of HK - 2 cells under high - glucose or TGF - β1 stimulation.

3. **Target gene verification**: Further research showed that MMP - 13 was the target gene of miR - 1470, and TIMP1 was the target gene of miR - 4483.

### Conclusion

This study revealed the important roles of miR - 1470 and miR - 4483 in renal fibrosis, providing potential directions for the development of new biomarkers and therapeutic targets. The research results are helpful for in - depth understanding of the regulatory mechanisms of miRNAs in renal fibrosis and provide new ideas for the treatment of chronic kidney disease.

### Keywords
Novel miRNAs, Chronic kidney disease, Renal fibrosis, Diabetic nephropathy, Focal segmental glomerulosclerosis